BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang C, Wang S, Zhao S, Zhang X. Effect of lanthanum carbonate on coronary artery calcification and bone mineral density in maintenance hemodialysis patients with diabetes complicated with adynamic bone disease: A prospective pilot study. Medicine (Baltimore) 2017;96:e8664. [PMID: 29137107 DOI: 10.1097/MD.0000000000008664] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Xu JP, Zeng RX, Liao PD, Zhang MZ. Effect of lanthanum carbonate on the progression of coronary artery calcification in hemodialysis patients: A meta-analysis of randomized controlled trials. Hemodial Int 2021. [PMID: 34897963 DOI: 10.1111/hdi.12988] [Reference Citation Analysis]
2 Silaghi CN, Ilyés T, Filip VP, Farcaș M, van Ballegooijen AJ, Crăciun AM. Vitamin K Dependent Proteins in Kidney Disease. Int J Mol Sci 2019;20:E1571. [PMID: 30934817 DOI: 10.3390/ijms20071571] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
3 Cernaro V, Calimeri S, Laudani A, Santoro D. Clinical Evaluation of the Safety, Efficacy and Tolerability of Lanthanum Carbonate in the Management of Hyperphosphatemia in Patients with End-Stage Renal Disease. Ther Clin Risk Manag 2020;16:871-80. [PMID: 32982259 DOI: 10.2147/TCRM.S196805] [Reference Citation Analysis]
4 Zhou T, Li H, Xie W, Lin Z. A meta-analysis of phosphate binders lanthanum carbonate versus sevelamer hydrochloride in patients with end-stage renal disease undergoing hemodialysis. Afr Health Sci 2018;18:689-96. [PMID: 30603002 DOI: 10.4314/ahs.v18i3.27] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 Grund A, Sinha MD, Haffner D, Leifheit-Nestler M. Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease-A Pediatric Perspective. Front Pediatr 2021;9:702719. [PMID: 34422725 DOI: 10.3389/fped.2021.702719] [Reference Citation Analysis]
6 Zhao L, Liu A, Xu G. Safety and effectiveness of lanthanum carbonate for hyperphosphatemia in chronic kidney disease (CKD) patients: a meta-analysis. Ren Fail 2021;43:1378-93. [PMID: 34602015 DOI: 10.1080/0886022X.2021.1986068] [Reference Citation Analysis]
7 Goto K, Goto S, Fujii H, Watanabe K, Kono K, Nishi S. Effects of lanthanum carbonate on bone markers and bone mineral density in incident hemodialysis patients. J Bone Miner Metab 2019;37:1075-82. [PMID: 31214836 DOI: 10.1007/s00774-019-01018-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Yang S, Niu Q, Gan L, Zhang X, Tu L, Zuo L. Effect of long-term use of unfractionated or low-molecular-weight heparin on bone mineral density in maintenance hemodialysis patients. Hemodial Int 2020;24:374-82. [PMID: 32520445 DOI: 10.1111/hdi.12854] [Reference Citation Analysis]
9 Ogata H, Fukagawa M, Hirakata H, Kagimura T, Fukushima M, Akizawa T; LANDMARK Investigators and Committees. Effect of Treating Hyperphosphatemia With Lanthanum Carbonate vs Calcium Carbonate on Cardiovascular Events in Patients With Chronic Kidney Disease Undergoing Hemodialysis: The LANDMARK Randomized Clinical Trial. JAMA 2021;325:1946-54. [PMID: 34003226 DOI: 10.1001/jama.2021.4807] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
10 Bouma-de Krijger A, Vervloet MG. Fibroblast growth factor 23: are we ready to use it in clinical practice? J Nephrol 2020;33:509-27. [PMID: 32130720 DOI: 10.1007/s40620-020-00715-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]